Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics

Lantheus Holdings, Inc. (LNTH): $63.29

0.43 (+0.68%)

POWR Rating

Component Grades














  • Sentiment is the dimension where LNTH ranks best; there it ranks ahead of 90.61% of US stocks.
  • LNTH's strongest trending metric is Growth; it's been moving up over the last 179 days.
  • LNTH ranks lowest in Momentum; there it ranks in the 19th percentile.

LNTH Stock Summary

  • The price/operating cash flow metric for Lantheus Holdings Inc is higher than 93.09% of stocks in our set with a positive cash flow.
  • Over the past twelve months, LNTH has reported earnings growth of 3,264.3%, putting it ahead of 99.13% of US stocks in our set.
  • In terms of volatility of its share price, LNTH is more volatile than 85.35% of stocks we're observing.
  • Stocks that are quantitatively similar to LNTH, based on their financial statements, market capitalization, and price volatility, are PWFL, REFR, BIOL, FCEL, and ROOT.
  • Visit LNTH's SEC page to see the company's official filings. To visit the company's web site, go to

LNTH Valuation Summary

  • LNTH's EV/EBIT ratio is -131.5; this is 548.81% lower than that of the median Healthcare stock.
  • Over the past 75 months, LNTH's EV/EBIT ratio has gone down 145.7.
  • LNTH's price/sales ratio has moved up 4.1 over the prior 75 months.

Below are key valuation metrics over time for LNTH.

Stock Date P/S P/B P/E EV/EBIT
LNTH 2021-08-31 4.7 3.5 -65.0 -131.5
LNTH 2021-08-30 4.7 3.5 -64.0 -129.6
LNTH 2021-08-27 4.6 3.4 -63.3 -128.3
LNTH 2021-08-26 4.5 3.3 -61.0 -123.9
LNTH 2021-08-25 4.5 3.3 -61.9 -125.7
LNTH 2021-08-24 4.5 3.4 -62.0 -125.9

LNTH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LNTH has a Quality Grade of C, ranking ahead of 29.96% of graded US stocks.
  • LNTH's asset turnover comes in at 0.436 -- ranking 105th of 682 Pharmaceutical Products stocks.
  • AVDL, OTIC, and SYRS are the stocks whose asset turnover ratios are most correlated with LNTH.

The table below shows LNTH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.436 0.431 -0.030
2021-03-31 0.393 0.416 0.016
2020-12-31 0.448 0.409 -0.004
2020-09-30 0.521 0.432 0.006
2020-06-30 0.634 0.452 0.034
2020-03-31 0.877 0.480 0.075

LNTH Price Target

For more insight on analysts targets of LNTH, see our LNTH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $32.00 Average Broker Recommendation 1.17 (Strong Buy)

LNTH Stock Price Chart Interactive Chart >

Price chart for LNTH

LNTH Price/Volume Stats

Current price $63.29 52-week high $69.74
Prev. close $62.86 52-week low $19.30
Day low $62.01 Volume 952,000
Day high $64.85 Avg. volume 1,060,832
50-day MA $58.64 Dividend yield N/A
200-day MA $35.68 Market Cap 4.34B

Lantheus Holdings, Inc. (LNTH) Company Bio

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company was founded in 1956 and is based in North Billerica, Massachusetts.

LNTH Latest News Stream

Event/Time News Detail
Loading, please wait...

LNTH Latest Social Stream

Loading social stream, please wait...

View Full LNTH Social Stream

Latest LNTH News From Around the Web

Below are the latest news stories about Lantheus Holdings Inc that investors may wish to consider to help them evaluate LNTH as an investment opportunity.

Lantheus Non-GAAP EPS of $0.25 beats by $0.08, revenue of $129.6M beats by $17.83M

Lantheus press release (NASDAQ:LNTH): Q4 Non-GAAP EPS of $0.25 beats by $0.08. Revenue of $129.6M (+37.6% Y/Y) beats by $17.83M....

Seeking Alpha | February 24, 2022

Lantheus Holdings, Inc. (LNTH) CEO Mary Anne Heino on Q4 2021 Results - Earnings Call Transcript

Lantheus Holdings, Inc. (LNTH) Q4 2021 Earnings Conference Call February 24, 2022, 8:00 AM ET Company Participants Mary Anne Heino – President and Chief Executive Officer Mark Kinarney – Senior Director of Investor Relations Paul Blanchfield – Chief Commercial Officer Robert Marshall – Chief Financial Officer and Treasurer Conference Call...

SA Transcripts on Seeking Alpha | February 24, 2022

Why Lantheus Holdings Stock Skyrocketed Today

Lantheus Holdings (NASDAQ: LNTH) had one of the best days of its life on the stock exchange Thursday. The specialty healthcare company saw its shares blast more than 39% higher on the strength of its latest earnings report, published that morning. For its Q4 of 2021, Lantheus earned just under $130 million in revenue, which was a nearly 38% improvement on a year-over-year basis.

Yahoo | February 24, 2022

Lantheus Holdings (LNTH) Q4 Earnings and Revenues Top Estimates

Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 47.06% and 14.81%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 24, 2022

Lantheus Holdings Earnings and Revenue Beat Pushes Shares 32% Higher

By Sam Boughedda

Yahoo | February 24, 2022

Read More 'LNTH' Stories Here

LNTH Price Returns

1-mo -0.74%
3-mo 119.38%
6-mo 120.60%
1-year 197.56%
3-year 155.92%
5-year 288.28%
YTD 119.07%
2021 114.16%
2020 -34.23%
2019 31.05%
2018 -23.47%
2017 137.79%

Continue Researching LNTH

Here are a few links from around the web to help you further your research on Lantheus Holdings Inc's stock as an investment opportunity:

Lantheus Holdings Inc (LNTH) Stock Price | Nasdaq
Lantheus Holdings Inc (LNTH) Stock Quote, History and News - Yahoo Finance
Lantheus Holdings Inc (LNTH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.4831 seconds.